Capstone Investment Advisors
DRTS icon

Capstone Investment Advisors’s Alpha Tau Medical DRTS Stock Holding History

Capstone Investment Advisors’s Portfolio DRTS Stock Details DRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-15,900
Closed -$188K – 1896
2022
Q1 		$188K Buy
+15,900
New +$187K ﹤0.01% 1775

Other funds holding DRTS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Capstone Investment Advisors's DRTS Position: Q2 2022 in Review

Capstone Investment Advisors sold out of Alpha Tau Medical (DRTS) in Q2 2022, closing a stake of 15,900 shares — an estimated $188K sold.

Capstone Investment Advisors first reported a position in DRTS in Q1 2022 and held it in 1 quarter. The position peaked at $188K in Q1 2022. 14 funds tracked by Wall St. Rank hold DRTS as of Q2 2022.

  • Capstone Investment Advisors reported no remaining Alpha Tau Medical position as of Q2 2022 after selling out during the quarter.
  • Capstone Investment Advisors sold 15,900 Alpha Tau Medical shares in Q2 2022, an estimated $188K.
  • Capstone Investment Advisors first reported a position in Alpha Tau Medical in Q1 2022 and held it in 1 quarter.
  • Capstone Investment Advisors's Alpha Tau Medical position peaked at $188K in Q1 2022.
  • 14 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q2 2022.

Based on Capstone Investment Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.